Episode 33 of the MAPS Podcast digs deep into the archives, all the way back to Psychedelic Science 2013! Matthew Baggott discussed research on how MDMA and related drugs alter emotions and social functioning in people.

Because the Phase 3 clinical trials moving full speed ahead it seemed appropriate to re-visit some of the core subject matter behind MDMA and why this research is so important.

Matthew Baggott, PhD, is a neuroscientist who has been studying the perceptual and emotional effects of drugs like MDMA in healthy human volunteers for over 13 years. He was part of the first team to receive federal funding to administer MDMA to healthy people and he co-authored the first successful application to administer MDMA to people with posttraumatic stress disorder (PTSD).

He earned his PhD in neuroscience from the University of California, Berkeley and is currently a postdoctoral fellow at University of Chicago.